ArticleCancers2024

Temozolomide and the PARP Inhibitor Niraparib Enhance Expression of Natural Killer Group 2D Ligand ULBP1 and Gamma-Delta T Cell Cytotoxicity in Glioblastoma.

Amber B Jones et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.